Clinical trials
Terminated Phase 2 Mesothelioma, Malignant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Verastem, Inc. | 2 |
| Aduro Biotech, Inc. | 1 |
| Arkadiusz Z. Dudek, MD | 1 |
| Burzynski Research Institute | 1 |
| Columbia University | 1 |
| Dana-Farber Cancer Institute | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Morphotek | 1 |
| National Cancer Institute (NCI) | 1 |
| PharmaMar | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 14 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Mesothelioma | 2 |
| Adenoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Glioblastoma | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.